Ren Bing Jun - Net Worth and Insider Trading

Ren Bing Jun Net Worth

The estimated net worth of Ren Bing Jun is at least $68 Million dollars as of 2024-11-13. Ren Bing Jun is the Director of Zhejiang Cheng Yi Pharmaceutical Co Ltd and owns about 8,067,437 shares of Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) stock worth over $68 Million. Details can be seen in Ren Bing Jun's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ren Bing Jun has not made any transactions after 2023-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ren Bing Jun

Ren Bing Jun Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ren Bing Jun owns 1 companies in total, including Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) .

Click here to see the complete history of Ren Bing Jun’s form 4 insider trades.

Insider Ownership Summary of Ren Bing Jun

Ticker	Comapny	Transaction Date	Type of Owner
SHSE:603811	Zhejiang Cheng Yi Pharmaceutical Co Ltd	2023-06-07	Director

Ren Bing Jun Latest Holdings Summary

Ren Bing Jun currently owns a total of 1 stock. Ren Bing Jun owns 8,067,437 shares of Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) as of June 7, 2023, with a value of $68 Million.

Latest Holdings of Ren Bing Jun

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SHSE:603811	Zhejiang Cheng Yi Pharmaceutical Co Ltd	2023-06-07	8,067,437	8.44	68,089,168

Holding Weightings of Ren Bing Jun

Ren Bing Jun Form 4 Trading Tracker

According to the SEC Form 4 filings, Ren Bing Jun has made a total of 6 transactions in Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zhejiang Cheng Yi Pharmaceutical Co Ltd is the sale of 2,304,982 shares on June 7, 2023, which brought Ren Bing Jun around $0.

Insider Trading History of Ren Bing Jun

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ren Bing Jun Trading Performance

GuruFocus tracks the stock performance after each of Ren Bing Jun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ren Bing Jun is -3.32%. GuruFocus also compares Ren Bing Jun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ren Bing Jun within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ren Bing Jun's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ren Bing Jun

Average Return

Average return per transaction

Outperforming Transactions

4 out of 5 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	10.46
Relative Return to S&P 500(%)	12.89

Ren Bing Jun Ownership Network

Ownership Network List of Ren Bing Jun

No Data

Ownership Network Relation of Ren Bing Jun

Ren Bing Jun Owned Company Details

What does Zhejiang Cheng Yi Pharmaceutical Co Ltd do?

Who are the key executives at Zhejiang Cheng Yi Pharmaceutical Co Ltd?

Ren Bing Jun is the Director of Zhejiang Cheng Yi Pharmaceutical Co Ltd. Other key executives at Zhejiang Cheng Yi Pharmaceutical Co Ltd include senior management Lv Sun Zhan , Supervisors Zhang Gao Qiao , and senior management Zhang Zhi Hong .

Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) Insider Trades Summary

Over the past 18 months, Ren Bing Jun made 1 insider transaction in Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) with a net sale of 0. Other recent insider transactions involving Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) include a net sale of 0 shares made by Li Shi Sheng , a net sale of 0 shares made by Ke Ze Hui , and a net sale of 0 shares made by Yan Yi Yi .

In summary, during the past 3 months, insiders sold 0 shares of Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Insider Transactions

No Available Data

Ren Bing Jun Mailing Address

Above is the net worth, insider trading, and ownership report for Ren Bing Jun. Currently GuruFocus does not have mailing address information for Ren Bing Jun.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.